Introduction
Duchenne muscular dystrophy (DMD) is an X-linked myopathy caused by the deficiency of dystrophin, a protein important for the stabilization of skeletal muscle fibres [1] . Dystrophin connects intracellular actin to the dystrophin-associated glycoprotein complex and protects against membrane damage from muscle contraction [2] .
Dystrophin is also important in the neuromuscular junction (NMJ), where it is enriched at the postsynaptic membrane [3] . In mdx mice, which lack dystrophin and display muscle weakness, NMJs show mild neuromuscular synaptic dysfunction and clear morphological deviations. We and others previously showed reduction of postsynaptic sensitivity for the neurotransmitter acetylcholine (ACh) and extra exhaustion of presynaptic ACh release during intense synaptic activity, causing a reduced safety factor of neuromuscular transmission [4, 5] . These functional changes are associated by fragmentation of the postsynaptic ACh receptor (AChR) cluster area [5, 6] . DMD patients may have similar NMJ abnormalities, indicated by an increased sensitivity to the AChR blocker d-tubocurarine and the prolonged duration of its effect, as compared to healthy controls [7] [8] [9] [10] [11] .
Therapies aiming to restore dystrophin expression in DMD are currently under investigation [12, 13] . Antisense oligonucleotides have been designed which restore the mRNA reading frame through exon-skipping so that internally deleted, but partly functional dystrophin protein is produced. In this way mdx mice have been successfully treated to Page 3 of 45 4 produce dystrophin with an associated improvement of muscle strength [14, 15] . Recent studies in DMD patients suggested slowing of disease progression [16, 17] . An exon 51 skipping oligonucleotide has received accelerated approval from the US Food and Drug Administration based on detected dystrophin levels of <1% of normal, although additional studies were requested to confirm functional effects [18] .
An important question arising in relation to these therapeutic studies is what level of dystrophin expression is minimally needed to stop muscle degeneration or even restore function. Female DMD carriers, heterozygous for the DMD mutation, are mostly asymptomatic and express ~50-65% of normal dystrophin protein [19] [20] [21] . However, some of them express (considerably) less than 50% dystrophin due to skewed X-inactivation and display clear symptoms of muscle weakness [21, 22] . This suggests that at least 50% dystrophin is necessary to support muscle function. On the other hand, in exon-skipped mdx mice, a dystrophin level of 15% of normal was shown to protect against muscle damage by forced eccentric contractions [23] . Higher levels of 40-80% dystrophin in addition caused improvement of basal muscle force as assessed in contraction experiments. Other studies in mdx 3cv mice and in heterozygous female mdx mice with low dystrophin levels due to transgenically induced skewness of X-inactivation revealed that levels of (near full-length or full-length) dystrophin as low as ~5-15% of normal already improved muscle function [24, 25] .
In the present study we investigated whether low levels of dystrophin have a beneficial role on the functional and morphological deviations at NMJs of mdx mice, which we reported recently [5] . To this end, mdx male mice were cross-bred with females homozygous for a mutation in the promoter of the Xist gene, which coordinates Xinactivation [26] . Their female mdx-Xist Δhs offspring expresses variable (but always low) full- length dystrophin levels, as a consequence of preferred inactivation of the wild-type X chromosome [25] . NMJ function and morphology of these mice was assessed and compared to that of heterozygous female mdx mice (mdx +/-), which express around 50% of normal dystrophin level [27, 28] , and homozygous female mdx mice.
Materials and Methods

Animals
Female mdx-Xist Δhs mice, expressing variable low levels of dystrophin were investigated.
They were compared to groups of female mdx and mdx +/-mice. The mdx-Xist Δhs mice were obtained through crossing mdx male mice with homozygous Xist Δhs female mice, which carry a mutation in the Xist promoter that coordinates X-inactivation [25, 26] . Due to the crossbreeding, mdx-Xist Δhs mice had a mixed genetic background of the C57BL/10ScSnJ and the Xist Δhs mice. We also included females of both these control strains in our comparisons in view of possible strain differences in NMJ parameters. C57BL/10ScSnJ and homozygous
Xist
Δhs female mice are assumed to express 100% dystrophin. We used mice of 2-5 months 6 The respiration signal was recorded for 120 s after 30 s acclimatization. The signal was digitized using a Minidigi digitizer and Axoscope 10 software (Axon Instruments/Molecular Devices, Sunnyvale, USA) and analysed with the event detection feature of the Clampfit 10 program (Axon Instruments/Molecular Devices).
The inverted mesh hanging test was used to assess fatigability of limb and abdominal muscles. To this end, mice were placed on an inverted grid forcing mice to hang using all four limbs. The mice were allowed three attempts to hang for maximal 240 s. If this maximal hang time was accomplished, the test was stopped. Otherwise the longest hanging time of the three attempts was used for analysis.
Forelimb grip strength was measured with a grip strength meter (type 303500, TSE Systems, Bad Homburg, Germany). Holding the mice at the base of the tail, they were allowed to grasp the pulling bar and were then gently pulled backwards until they released.
Ten successive pulls were done with a few seconds pause in between. The mean value was divided by the body weight to obtain the normalized grip strength (g force per g body weight).
Compound muscle action potentials (CMAPs) during repetitive sciatic nerve stimulationelectromyography were recorded from the left calf muscles of ketamine/medetomidine anesthetized mice as described previously [5] .
After completing the electromyography recordings, before recovery from anaesthesia, mice were killed by carbon dioxide inhalation. Diaphragm and epitrochleoanconeus (ETA) muscles were quickly dissected for the electrophysiological and morphological studies described below. Dissected muscles were placed in Ringer's medium at room temperature (20-22 °C) , containing (in mM): NaCl 116, KCl 4.5, CaCl 2 2, MgCl 2 1, NaH 2 PO 4 1, NaHCO 3 23, glucose 11, pH 7.4, bubbled with a 95% O 2 and 5% CO 2 gas mixture. 
Dystrophin level determination
After electrophysiological analysis, the remaining part of the right hemidiaphragm muscles of all mdx-Xist Δhs mice was snap frozen in liquid nitrogen and stored for later analysis at -80C. After thawing, samples were homogenized and protein concentration was determined using the BCA protein assay kit (Thermo Fischer Scientific, The Netherlands). Dystrophin levels were determined by western blot using the Trans-Blot Turbo system (Bio-Rad, Veenendaal, The Netherlands) according to the protocol of Hulsker et al. [30] . Pooled lysates isolated from tissues from the C57BL/10ScSnJ wild-type controls were used as 100% dystrophin control. For the generation of a calibration curve, serial dilutions of this material were made in mdx lysates to ensure equal loading of total protein in each lane. Membranes were stained with NCL-DYS1 for dystrophin (1:125, Novocastra, UK) and alpha actinin Li-Cor, USA) were used as secondary antibodies. Blots were visualized and quantified with the Odyssey system and software (Li-Cor). sampled. Statistical significances were assessed using ANOVA, and Tukey's honestly post hoc test in case of a statistically significant ANOVA test. The differences in mean data from the two groups of mdx-Xist Δhs mice with dystrophin levels lower than 6% or higher than 6% were statistically tested with Student's t-test. To assess a possible dependence of the obtained parameters in mdx-Xist Δhs mice on the dystrophin levels, linear regression was performed and it was tested whether the slope of the fitted line deviated statistically significantly from zero. All statistical analyses were performed using GraphPad Prism 6 (GraphPad Software, Inc. La Jolla, CA, USA); differences with P-values <0.05 were considered statistically significant. If a statistically significant difference was found, this is indicated in the graphs, together with the obtained P-value.
Statistical analyses
Results
To investigate whether low dystrophin levels prevent NMJ deviations in dystrophic muscle, female mdx (0% dystrophin), mdx-Xist Δhs (variable, low percentages dystrophin), mdx muscle of the 20 mdx-Xist Δhs studied mice revealed that the levels were low, varying between ~2 and ~19% of normal ( Fig. 1 ). The group average was 7.5  1.1%. Based on the distribution of the dystrophin levels of individual mdx-Xist Δhs mice, we separated them into two groups for statistical comparison, one with levels lower than 6% (mdx-Xist Δhs <6%; mean 3.9  0.4%; n=10) and one with levels of more than 6% (mdx-Xist Δhs >6%; mean 11.0  1.5%; n=10).
In vivo performance tests
To determine the in vivo effects of the low dystrophin levels, mice were weighed and tested for respiratory function, inverted mesh hanging and grip-strength. Mdx-Xist Δhs and mdx mice did not differ in mean body weight, but were both ~30% heavier than the controls groups C57BL10/ScSnJ and Xist Δhs (i.e. the homozygous Xist Δhs mice, which carry a mutation in the Xist promoter that coordinates X-inactivation, and have 100% dystrophin) ( Fig. 2A) . In whole body plethysmography, the respiration amplitude (absolute as well as body weightnormalized) and rate did not differ between the mouse strains, except for the mdx-Xist (Fig. 5B, 6 ). No correlation between mean MEPP amplitude and dystrophin level of individual mdx-Xist Δhs mice was observed (Fig. 5C) . MEPP amplitudes at mdx +/-NMJs, however, equalled those of control strains NMJs. The frequency of MEPPs did not differ statistically significantly amongst the strains (Fig. 5D ). The 10-90% rise time of the MEPPs was increased by ~25% at mdx NMJs, as compared to C57BL/10ScSnJ control, mdx +/-as well as mdx-Xist Δhs NMJs (Fig. 5E ). However, no correlation between mean MEPP rise time and dystrophin level of individual mdx-Xist Δhs mice was observed (Fig. 5F ). Mean mdx-Xist Δhs MEPP rise time was similar to the Xist Δhs controls. Amongst the different strains there was no difference in the mean intra-NMJ variation coefficient (VC) of the MEPP amplitude (Fig.   5G ). Inter-NMJ VC of the mean MEPP amplitude within muscles was increased in mdx-Xist Δhs and mdx mice, as compared to C57BL/10ScSnJ control muscles (Fig. 5H) (Fig. 6, 7A ). This was only statistically significant in comparison to the mdx +/-group. The 10-90% rise time of these EPPs in mdx NMJs was ~25%
increased as compared to the C57BL/10ScSnJ control and mdx +/-NMJs (Fig. 7B) . Half-width of the EPPs was increased by ~15% in mdx-Xist Δhs and mdx mice compared to C57BL/10ScSnJ. In addition, the half-width of EPPs in mdx NMJs was also increased compared to Xist Δhs and mdx +/-NMJs (Fig. 7C) . Furthermore, the EPP decay time was increased by ~30% in the mdx-Xist Δhs and mdx NMJs, compared with C57BL/10ScSnJ control.
The Xist Δhs control differed only from the mdx mice (Fig. 7D) . The half-width and decay time NMJs showed no deficits in synaptic electrophysiology; apparently the ~50% dystrophin level is sufficient for normal NMJ function.
AChR cluster fragmentation is retained in low level dystrophin NMJs
In a proportion of the functionally studied mice, AChR geometry and dystrophin localization at NMJs was studied with (immuno-)fluorescence confocal laser-scanning microscopy. Clear
AChR cluster fragmentation was present in mdx as well as mdx-Xist Δhs NMJs (Fig. 8A) (Fig. 8C) . A proportion of the mdxXist Δhs NMJs had control-like NMJ appearance, i.e. only a few AChR islets and a more or less intact pretzel-shaped structure. Such NMJs were encountered in any area within the muscle, with no apparent grouped localization.
High-magnification immunofluorescence confocal laser-scanning microscopy of mdxXist
Δhs ETA muscles revealed variable, but generally low-intense dystrophin staining at most NMJs, which roughly but certainly not exactly co-localized with the area stained for AChR with fluorescently labelled α-BTx (Fig. 9A) . Mdx +/-NMJs had a similar AChR and dystrophin morphological appearance as C57BL/10ScSnJ and Xist Δhs controls, while mdx NMJs clearly showed AChR cluster fragmentation and absence of dystrophin (Fig. 9B ).
Discussion
With therapies emerging that aim to restore dystrophin protein in muscles to treat or slow down DMD [31, 32] , it is important to know the rescuing effects of low percentages dystrophin protein on all different components of the muscle. This includes the effects on functional and morphological aberrations at the dystrophic NMJ, such as reduced safety factor of neuromuscular transmission and AChR cluster fragmentation, demonstrated by us previously in DMD mouse models [5] . Here we show in mice expressing only ~2-19% of normal dystrophin in their diaphragm, that there is virtually no normalization of the deficits in synaptic signalling and morphology of the NMJ. We also demonstrate that NMJ function and morphology of mdx +/-mice, expressing ~50% of normal dystrophin, is near-normal.
Thus, our study shows that presence of less than ~19% of the normal level of dystrophin protein is insufficient to normalize the NMJ deficits of mdx mice, but that ~50% of normal dystrophin level seems to be enough for normal synaptic function of the NMJ. breeding colonies as used in the current study), a wider range of dystrophin percentages was found of 3-47% of normal, and a higher group mean of 22.7% [25] . Dystrophin levels in that study were determined in quadriceps muscle, which was shown in a sample of 6 mdxXist Δhs mice in the same study to express on average ~50% more dystrophin than the diaphragm muscle of those mice. However, this explains only a part of the much lower range and mean of dystrophin protein levels observed in the current series. Apparently, series variation exists due to (subtle) differences in the skewedness of X chromosomal silencing in the mdx-Xist Δhs model. Perhaps, litter dependent effects are also involved.
In vivo strength and endurance tests showed muscle weakness in mdx mice, as compared to the control strains. Although there were slight tendencies of improvement, no statistically significant changes were observed for the mdx-Xist Δhs mice as compared to mdx, and no positive correlation was seen in linear regression when the grip strength of individual mice was plotted against their dystrophin level. The subtle improvements as compared to mdx may even have resulted from the mixed genetic background of mdx-Xist Δhs mice, which is the inherent result of mdx-Xist Δhs mice being produced by matings of Xist Δhs females, which have a C57BL/6 X CBA background [26] and male mdx mice which have a C57BL/10ScSnJ background. For completeness, we included females of both these control strains in our studies. We observed that they were similar for most of the in vivo parameters but differed to quite some extent in the body weight-normalized grip strength parameter, mice, as compared to the mdx mice, which have a pure C57BL/10ScSnJ genetic background.
The lack of clear muscle strength improvement in mdx-Xist Δhs mice seems to differ from an earlier study which reported strength increases in mdx-Xist Δhs mice, even with dystrophin percentages in the lowest category (<15%), as assessed in quadriceps muscle and thus with diaphragm dystrophin percentages probably in the range of the current series [25] .
Furthermore, mdx 3cv mice expressing ~5% dystrophin, as assessed in tibialis anterior, have been shown to have more muscle strength than mdx 4cv mice, which have no dystrophin at all [24] . In addition, ~5% dystrophin expressed in an mdx 3cv /utrn -/-compound mutant strain drastically improved the phenotype, as compared to mdx/utrn -/-mice without dystrophin [33] . Similarly, mdx/utrn -/--Xist Δhs mice with percentages dystrophin below 4% clearly improved [34] . The reasons for the apparent discrepancies with the current set of mdxXist Δhs mice remain unclear.
In vivo repetitive nerve stimulation electromyography showed that mdx-Xist Δhs mice had a somewhat larger first CMAP than mdx mice. However, this was probably due to the mixed genetic background of mdx-Xist Δhs mice, because the first CMAP of Xist Δhs control mice was found to be ~40% larger than that of C57BL/10ScSnJ control mice, the latter forming the genetic background of mdx mice. A normal initial CMAP amplitude was observed by us in the mdx +/-mice, when compared to the matching C57BL/10ScSnJ control. The decrement of CMAPs during the repetitive nerve stimulation in both the C57BL/10ScSnJ and Xist Δhs control strains was negligible, indicating sustained synaptic transmission of NMJs. In the mdx +/-,
mdx-Xist
Δhs and mdx mice a trend of an increasing extent of CMAP decrement was found, statistically significant only for the mdx group, which had ~7% decrement. This suggests mild NMJ dysfunction resulting in use-dependent block in a proportion of NMJs during intense activity. Apparently, the levels of dystrophin in the investigated mdx-Xist Δhs mice were still [20, 35, 36] , to our knowledge no human electromyography data is published on CMAP decrement upon repetitive nerve stimulation.
As stated above, dystrophin levels in limb muscles of mdx-Xist Δhs mice are most likely ~50% higher than in diaphragm [25] . We have no indication that the dystrophin levels of limb and diaphragm muscles would not be correlated in individual mice. Therefore, although the exact percentage value as determined in diaphragm muscle might not apply to the muscles responsible for performance in the grip strength test, inverted mesh test and electromyography, the inter-mouse dystrophin level variation pattern was likely similar to that established from diaphragm dystrophin level analysis. Additional normalization of the reduced postsynaptic ACh sensitivity seems to be only possible when dystrophin is expressed at levels (much) higher than 19%.
Similarly, the postsynaptic morphological deviations of dystrophin-deficient NMJs, i.e. the fragmented AChR clusters, were on average not normalized. However, a small minority of the mdx-Xist Δhs diaphragm NMJs had control-like AChR cluster appearance, i.e. a pretzelshaped geometry with only few separate islets. In further studies, it would be interesting to specifically measure the synaptic signals at such NMJs to see if the morphological normalization is associated with normalized electrophysiology.
Each mouse skeletal muscle fibre possesses one hundred to a few hundreds of nuclei which are regularly spaced over the whole fibre with ~30 μm internuclei distance. An exception is present at the postsynaptic membrane of the NMJ, where a subsynaptic cluster of on average four nuclei exists with only 11-14 μm internuclei distance [37] . Nuclei in mdxXist Δhs muscle fibres express dystrophin mRNA at either wild-type level or not at all, leading to a patchy dystrophin presence along the sarcolemma [25] . However, at their NMJs (if they expressed dystrophin at all) such a patchy occurrence of dystrophin was not observed in the 
Conclusions
In the current study, most of the reported electrophysiological and morphological 
